Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chandrasekaran Padmapriyadarsini

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Clinical Pharmacology and Therapeutics|November 20, 2023
A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in TuberculosisChandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar, et al.
Annals of the American Thoracic Society|December 1, 2023
Early Microbiologic Markers of Pulmonary Tuberculosis Treatment OutcomesMandar Sudhir Paradkar, Neeta Nitin Pradhan, Subramanyam Balaji, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
A dose-finding study to guide use of verapamil as an adjunctive therapy in tuberculosisChandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|June 22, 2019
Age-specific prevalence of TB infection among household contacts of pulmonary TB: Is it time for TB preventive therapy?Chandra Kumar Dolla, Chandrasekaran Padmapriyadarsini, Kannan Thiruvengadam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2022
Whole Genome Sequencing Assessing Impact of Diabetes Mellitus on Tuberculosis Mutations and Type of Recurrence in IndiaVidya Mave, Liang Chen, Uma Devi Ranganathan, et al.
The European Respiratory Journal|October 29, 2021
Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation studyAkshay N Gupte, Pavan Kumar, Mariana Araújo-Pereira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 25, 2022
Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort AnalysisPranay Sinha, Chinnaiyan Ponnuraja, Nikhil Gupte, et al.
The European Respiratory Journal|August 10, 2021
Host lipidome and tuberculosis treatment failureRupak Shivakoti, John W Newman, Luke Elizabeth Hanna, et al.
Chest|September 12, 2025
Contribution of Key Comorbidities to Unfavorable Treatment Outcomes Among Adults With Drug-Sensitive Pulmonary TB in India: A Prospective Cohort AnalysisPranay Sinha, Meagan Karoly, Chandrasekaran Padmapriyadarsini, et al.
Plos One|July 30, 2020
Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in IndiaMandar Paradkar, Chandrasekaran Padmapriyadarsini, Divyashri Jain, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Clinical Pharmacology and Therapeutics|November 20, 2023
A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in TuberculosisChandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar, et al.
Annals of the American Thoracic Society|December 1, 2023
Early Microbiologic Markers of Pulmonary Tuberculosis Treatment OutcomesMandar Sudhir Paradkar, Neeta Nitin Pradhan, Subramanyam Balaji, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
A dose-finding study to guide use of verapamil as an adjunctive therapy in tuberculosisChandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|June 22, 2019
Age-specific prevalence of TB infection among household contacts of pulmonary TB: Is it time for TB preventive therapy?Chandra Kumar Dolla, Chandrasekaran Padmapriyadarsini, Kannan Thiruvengadam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2022
Whole Genome Sequencing Assessing Impact of Diabetes Mellitus on Tuberculosis Mutations and Type of Recurrence in IndiaVidya Mave, Liang Chen, Uma Devi Ranganathan, et al.
The European Respiratory Journal|October 29, 2021
Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation studyAkshay N Gupte, Pavan Kumar, Mariana Araújo-Pereira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 25, 2022
Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort AnalysisPranay Sinha, Chinnaiyan Ponnuraja, Nikhil Gupte, et al.
The European Respiratory Journal|August 10, 2021
Host lipidome and tuberculosis treatment failureRupak Shivakoti, John W Newman, Luke Elizabeth Hanna, et al.
Chest|September 12, 2025
Contribution of Key Comorbidities to Unfavorable Treatment Outcomes Among Adults With Drug-Sensitive Pulmonary TB in India: A Prospective Cohort AnalysisPranay Sinha, Meagan Karoly, Chandrasekaran Padmapriyadarsini, et al.
Plos One|July 30, 2020
Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in IndiaMandar Paradkar, Chandrasekaran Padmapriyadarsini, Divyashri Jain, et al.
Pageof 8